Mumbai Reports Increase in Chikungunya, Hepatitis, Malaria Cases

According to local news, Mumbaī has reported an increase in malaria, chikungunya, and hepatitis cases this year compared to the same period in 2024.

The Brihanmumbai Municipal Corporation (BMC) in its Monsoon-Diseases report showed 6,277 cases of malaria from January to September 15, 2025, compared to 5,182 in the same period the previous year.

There were 913 cases of hepatitis, against 791, and 542 cases of chikungunya, up from 366 in 2024.

However, cases of dengue, leptospirosis, and gastroenteritis witnessed a decline this year.

Mumbaī is the capital city of the Indian state of Maharashtra, with a population exceeding 12 million, and is visited by millions of visitors annually.

The U.S. Centers for Disease Control and Prevention (CDC) reports an elevated risk of chikungunya and hepatitis in India, and vaccination may be considered for individuals traveling or relocating to this area if they plan to stay for an extended period.

As of September 18, 2025, dengue and malaria vaccines are unavailable for international travelers departing from the USA.